APA

de Jonge M. J. A., van der Gaast A., Planting A. S. T., van Doorn L., Lems A., Boot I., Wanders J., Satomi M. & Verweij J. (20050823). Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Chicago

de Jonge Maja J A, van der Gaast Ate, Planting André S T, van Doorn Leny, Lems Aletta, Boot Inge, Wanders Jantien, Satomi Masahiko and Verweij Jaap. 20050823. Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

Harvard

de Jonge M. J. A., van der Gaast A., Planting A. S. T., van Doorn L., Lems A., Boot I., Wanders J., Satomi M. and Verweij J. (20050823). Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research.

MLA

de Jonge Maja J A, van der Gaast Ate, Planting André S T, van Doorn Leny, Lems Aletta, Boot Inge, Wanders Jantien, Satomi Masahiko and Verweij Jaap. Phase I and pharmacokinetic study of the dolastatin 10 analogue TZT-1027, given on days 1 and 8 of a 3-week cycle in patients with advanced solid tumors. : Clinical cancer research : an official journal of the American Association for Cancer Research. 20050823.